Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UBS analyst Danielle Antalffy maintains Medtronic (NYSE:MDT) with a Neutral and raises the price target from $95 to $102.
Wells Fargo analyst Larry Biegelsen maintains Medtronic (NYSE:MDT) with a Overweight and raises the price target from $100 t...
Baird analyst David Rescott maintains Medtronic (NYSE:MDT) with a Neutral and raises the price target from $103 to $109.
Goldman Sachs analyst David Roman upgrades Medtronic (NYSE:MDT) from Sell to Neutral and raises the price target from $81 to...
The CNN Money Fear and Greed index rose in fear level, remaining in Extreme Fear zone. U.S. stocks fell ahead of highly anticip...
Wall Street endured another wave of selling in tech stocks on Tuesday, with the Nasdaq 100 down more than 1% by midday in New Y...
- Reuters Citing Conf Call
Medtronic reports strong Q2 2026 results with sales of around $9 billion, surpassing estimates. Organic growth at 5.5%.
